{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:41:08Z","timestamp":1792802468777,"version":"4.5.0"},"reference-count":39,"publisher":"Wiley","issue":"14","license":[{"start":{"date-parts":[[2015,5,27]],"date-time":"2015-05-27T00:00:00Z","timestamp":1432684800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2015,5,27]],"date-time":"2015-05-27T00:00:00Z","timestamp":1432684800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"name":"ASCO YIA and ECOG Paul Carbone Fellowship"},{"name":"Analytical Pharmacology Core of the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins"},{"name":"NIH","award":["P30 CA006973"],"award-info":[{"award-number":["P30 CA006973"]}]},{"name":"NIH","award":["UL1 TR 001079"],"award-info":[{"award-number":["UL1 TR 001079"]}]},{"name":"Shared Instrument Grant","award":["1S10RR026824-01"],"award-info":[{"award-number":["1S10RR026824-01"]}]},{"name":"Community Foundation of the National Capital Region"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Prostate"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1002\/pros.23024","type":"journal-article","created":{"date-parts":[[2015,5,27]],"date-time":"2015-05-27T17:05:49Z","timestamp":1432746349000},"page":"1518-1525","source":"Crossref","is-referenced-by-count":122,"title":["A phase I study of muscadine grape skin extract in men with biochemically recurrent prostate cancer: Safety, tolerability, and dose determination"],"prefix":"10.1002","volume":"75","author":[{"given":"Channing J.","family":"Paller","sequence":"first","affiliation":[{"name":"Sidney Kimmel Comprehensive Cancer Center; Johns Hopkins Medical Institutions; Baltimore Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle A.","family":"Rudek","sequence":"additional","affiliation":[{"name":"Sidney Kimmel Comprehensive Cancer Center; Johns Hopkins Medical Institutions; Baltimore Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xian C.","family":"Zhou","sequence":"additional","affiliation":[{"name":"Sidney Kimmel Comprehensive Cancer Center; Johns Hopkins Medical Institutions; Baltimore Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William D.","family":"Wagner","sequence":"additional","affiliation":[{"name":"Wake Forest University School of Medicine; Winston-Salem North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamaro S.","family":"Hudson","sequence":"additional","affiliation":[{"name":"Howard University Cancer Center; Washington, District of Columbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Anders","sequence":"additional","affiliation":[{"name":"Sidney Kimmel Comprehensive Cancer Center; Johns Hopkins Medical Institutions; Baltimore Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans J.","family":"Hammers","sequence":"additional","affiliation":[{"name":"Sidney Kimmel Comprehensive Cancer Center; Johns Hopkins Medical Institutions; Baltimore Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna","family":"Dowling","sequence":"additional","affiliation":[{"name":"Sidney Kimmel Comprehensive Cancer Center; Johns Hopkins Medical Institutions; Baltimore Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serina","family":"King","sequence":"additional","affiliation":[{"name":"Sidney Kimmel Comprehensive Cancer Center; Johns Hopkins Medical Institutions; Baltimore Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel S.","family":"Antonarakis","sequence":"additional","affiliation":[{"name":"Sidney Kimmel Comprehensive Cancer Center; Johns Hopkins Medical Institutions; Baltimore Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles G.","family":"Drake","sequence":"additional","affiliation":[{"name":"Sidney Kimmel Comprehensive Cancer Center; Johns Hopkins Medical Institutions; Baltimore Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario A.","family":"Eisenberger","sequence":"additional","affiliation":[{"name":"Sidney Kimmel Comprehensive Cancer Center; Johns Hopkins Medical Institutions; Baltimore Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel R.","family":"Denmeade","sequence":"additional","affiliation":[{"name":"Sidney Kimmel Comprehensive Cancer Center; Johns Hopkins Medical Institutions; Baltimore Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary L.","family":"Rosner","sequence":"additional","affiliation":[{"name":"Sidney Kimmel Comprehensive Cancer Center; Johns Hopkins Medical Institutions; Baltimore Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Carducci","sequence":"additional","affiliation":[{"name":"Sidney Kimmel Comprehensive Cancer Center; Johns Hopkins Medical Institutions; Baltimore Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2015,5,27]]},"reference":[{"issue":"1","key":"10.1002\/pros.23024-BIB0001|pros23024-cit-0001","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3322\/caac.21254","article-title":"Cancer statistics, 2015","volume":"65","author":"Siegel","year":"2015","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"10.1002\/pros.23024-BIB0002|pros23024-cit-0002","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/j.hoc.2013.08.005","article-title":"Management of patients with biochemical recurrence after local therapy for prostate cancer","volume":"27","author":"Paller","year":"2013","journal-title":"Hematol Oncol Clin North Am"},{"issue":"15","key":"10.1002\/pros.23024-BIB0003|pros23024-cit-0003","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1001\/archinternmed.2010.262","article-title":"Impact of biochemical recurrence in prostate cancer among US veterans","volume":"170","author":"Uchio","year":"2010","journal-title":"Arch Intern Med"},{"issue":"11","key":"10.1002\/pros.23024-BIB0004|pros23024-cit-0004","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.1093\/annonc\/mdt335","article-title":"Metastasis-free survival is associated with overall survival in men with PSA-recurrent prostate cancer treated with deferred androgen deprivation therapy","volume":"24","author":"Schweizer","year":"2013","journal-title":"Ann Oncol"},{"issue":"5","key":"10.1002\/pros.23024-BIB0005|pros23024-cit-0005","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1634\/theoncologist.8-5-474","article-title":"Andropause: Symptom management for prostate cancer patients treated with hormonal ablation","volume":"8","author":"Thompson","year":"2003","journal-title":"Oncologist"},{"issue":"1","key":"10.1002\/pros.23024-BIB0006|pros23024-cit-0006","first-page":"14","article-title":"Management of biochemically recurrent prostate cancer after local therapy: Evolving standards of care and new directions","volume":"11","author":"Paller","year":"2013","journal-title":"Clin Adv Hematol Oncol"},{"issue":"17","key":"10.1002\/pros.23024-BIB0007|pros23024-cit-0007","doi-asserted-by":"crossref","first-page":"8396","DOI":"10.1158\/0008-5472.CAN-06-4069","article-title":"Inhibition of prostate cancer growth by muscadine grape skin extract and resveratrol through distinct mechanisms","volume":"67","author":"Hudson","year":"2007","journal-title":"Cancer Res"},{"issue":"22","key":"10.1002\/pros.23024-BIB0008|pros23024-cit-0008","doi-asserted-by":"crossref","first-page":"8804","DOI":"10.1021\/jf0515328","article-title":"Study of anticancer activities of muscadine grape phenolics in vitro","volume":"53","author":"Yi","year":"2005","journal-title":"J Agric Food Chem"},{"issue":"4","key":"10.1002\/pros.23024-BIB0009|pros23024-cit-0009","doi-asserted-by":"crossref","first-page":"542","DOI":"10.18632\/oncotarget.923","article-title":"Galectin-3: A possible complementary marker to the PSA blood test","volume":"4","author":"Balan","year":"2013","journal-title":"Oncotarget"},{"issue":"2","key":"10.1002\/pros.23024-BIB0010|pros23024-cit-0010","doi-asserted-by":"crossref","first-page":"622","DOI":"10.3390\/ijms11020622","article-title":"Biological activities of polyphenols from grapes","volume":"11","author":"Xia","year":"2010","journal-title":"Int J Mol Sci"},{"issue":"19","key":"10.1002\/pros.23024-BIB0011|pros23024-cit-0011","doi-asserted-by":"crossref","first-page":"7732","DOI":"10.1021\/jf071303g","article-title":"Pomegranate ellagitannin-derived metabolites inhibit prostate cancer growth and localize to the mouse prostate gland","volume":"55","author":"Seeram","year":"2007","journal-title":"J Agric Food Chem"},{"issue":"3","key":"10.1002\/pros.23024-BIB0012|pros23024-cit-0012","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1021\/jf052005r","article-title":"Pomegranate juice, total pomegranate ellagitannins, and punicalagin suppress inflammatory cell signaling in colon cancer cells","volume":"54","author":"Adams","year":"2006","journal-title":"J Agric Food Chem"},{"issue":"3","key":"10.1002\/pros.23024-BIB0013|pros23024-cit-0013","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1093\/carcin\/22.3.409","article-title":"Quercetin inhibits the expression and function of the androgen receptor in LNCaP prostate cancer cells","volume":"22","author":"Xing","year":"2001","journal-title":"Carcinogenesis"},{"issue":"1","key":"10.1002\/pros.23024-BIB0014|pros23024-cit-0014","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1128\/CDLI.11.1.63-69.2004","article-title":"Inhibition of prostate cancer cell colony formation by the flavonoid quercetin correlates with modulation of specific regulatory genes","volume":"11","author":"Nair","year":"2004","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1002\/pros.23024-BIB0015|pros23024-cit-0015","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0065-2571(96)00025-8","article-title":"Regulation of the signal transduction program by drugs","volume":"37","author":"Weber","year":"1997","journal-title":"Adv Enzyme Regul"},{"issue":"8","key":"10.1002\/pros.23024-BIB0016|pros23024-cit-0016","first-page":"1605","article-title":"Flavonoids activate wild-type p53","volume":"13","author":"Plaumann","year":"1996","journal-title":"Oncogene"},{"issue":"5","key":"10.1002\/pros.23024-BIB0017|pros23024-cit-0017","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1002\/ijc.10202","article-title":"Food-derived polyphenols inhibit pancreatic cancer growth through mitochondrial cytochrome C release and apoptosis","volume":"98","author":"Mouria","year":"2002","journal-title":"Int J Cancer"},{"issue":"4","key":"10.1002\/pros.23024-BIB0018|pros23024-cit-0018","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/sj.pcan.4500895","article-title":"Lycopene inhibits DNA synthesis in primary prostate epithelial cells in vitro and its administration is associated with a reduced prostate-specific antigen velocity in a phase II clinical study","volume":"9","author":"Barber","year":"2006","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"2","key":"10.1002\/pros.23024-BIB0019|pros23024-cit-0019","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1080\/01635580701621338","article-title":"A combination of tomato and soy products for men with recurring prostate cancer and rising prostate specific antigen","volume":"60","author":"Grainger","year":"2008","journal-title":"Nutr Cancer"},{"issue":"1","key":"10.1002\/pros.23024-BIB0020|pros23024-cit-0020","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/pcan.2012.20","article-title":"A randomized phase II study of pomegranate extract for men with rising PSA following initial therapy for localized prostate cancer","volume":"16","author":"Paller","year":"2013","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"2","key":"10.1002\/pros.23024-BIB0021|pros23024-cit-0021","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/pcan.2014.6","article-title":"A double-blind, placebo-controlled randomised trial evaluating the effect of a polyphenol-rich whole food supplement on PSA progression in men with prostate cancer-the U.K. NCRN Pomi-T study","volume":"17","author":"Thomas","year":"2014","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"6","key":"10.1002\/pros.23024-BIB0022|pros23024-cit-0022","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1002\/cncr.26437","article-title":"Changes in PSA kinetics predict metastasis- free survival in men with PSA-recurrent prostate cancer treated with nonhormonal agents: Combined analysis of 4 phase II trials","volume":"118","author":"Antonarakis","year":"2012","journal-title":"Cancer"},{"issue":"1","key":"10.1002\/pros.23024-BIB0023|pros23024-cit-0023","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/pcan.2014.44","article-title":"Change in PSA velocity is a predictor of overall survival in men with biochemically-recurrent prostate cancer treated with nonhormonal agents: Combined analysis of four phase-2 trials","volume":"18","author":"Suzman","year":"2015","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"7","key":"10.1002\/pros.23024-BIB0024|pros23024-cit-0024","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1200\/JCO.2007.12.4487","article-title":"Design and end points of clinical trials for patients with progressive prostate cancer and castrate levels of testosterone: Recommendations of the Prostate Cancer Clinical Trials Working Group","volume":"26","author":"Scher","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1002\/pros.23024-BIB0025|pros23024-cit-0025","doi-asserted-by":"crossref","DOI":"10.1200\/jco.2013.31.15_suppl.2061","article-title":"Safety interim data from a 3-arm phase 2 study evaluating safety and pharmacokinetics of the oral transforming growth factor-beta receptor I kinase inhibitor LY 2157 299 monohydrate in patients with glioblastoma at first progression","volume":"31","author":"Carpentier","year":"2013","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1002\/pros.23024-BIB0026|pros23024-cit-0026","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1016\/j.juro.2008.01.099","article-title":"Prostate Specific Antigen Working Group guidelines on prostate specific antigen doubling time","volume":"179","author":"Arlen","year":"2008","journal-title":"J Urol"},{"issue":"3","key":"10.1002\/pros.23024-BIB0027|pros23024-cit-0027","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1080\/10543400902800486","article-title":"Continual reassessment method vs. traditional empirically based design: Modifications motivated by Phase I trials in pediatric oncology by the Pediatric Brain Tumor Consortium","volume":"19","author":"Onar","year":"2009","journal-title":"J Biopharm Stat"},{"issue":"1","key":"10.1002\/pros.23024-BIB0028|pros23024-cit-0028","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1191\/1740774506cn134oa","article-title":"The continual reassessment method for dose-finding studies: A tutorial","volume":"3","author":"Garrett-Mayer","year":"2006","journal-title":"Clin Trials"},{"issue":"4","key":"10.1002\/pros.23024-BIB0029|pros23024-cit-0029","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1001\/jama.294.4.433","article-title":"Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy","volume":"294","author":"Freedland","year":"2005","journal-title":"JAMA"},{"issue":"4","key":"10.1002\/pros.23024-BIB0030|pros23024-cit-0030","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1200\/JCO.2007.13.5905","article-title":"Vitamin and mineral supplement use among US adults after cancer diagnosis: A systematic review","volume":"26","author":"Velicer","year":"2008","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1002\/pros.23024-BIB0031|pros23024-cit-0031","first-page":"323","article-title":"Changes in diet, physical activity, and supplement use among adults diagnosed with cancer","volume":"103","author":"Patterson","year":"2003","journal-title":"J Am Diet Assoc"},{"key":"10.1002\/pros.23024-BIB0032|pros23024-cit-0032","unstructured":"https:\/\/www.ftc.gov\/news-events\/press-releases\/2013\/01\/ftc-commissioners-uphold-trial-judge-decision-pom-wonderful-llc"},{"issue":"14","key":"10.1002\/pros.23024-BIB0033|pros23024-cit-0033","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1001\/jama.2011.1437","article-title":"Vitamin E and the risk of prostate cancer: The Selenium and Vitamin E Cancer Prevention Trial (SELECT)","volume":"306","author":"Klein","year":"2011","journal-title":"JAMA"},{"issue":"27","key":"10.1002\/pros.23024-BIB0034|pros23024-cit-0034","doi-asserted-by":"crossref","first-page":"4448","DOI":"10.1200\/JCO.2006.06.2497","article-title":"Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer","volume":"24","author":"Keating","year":"2006","journal-title":"J Clin Oncol"},{"issue":"20","key":"10.1002\/pros.23024-BIB0035|pros23024-cit-0035","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.2174\/09298673113209990120","article-title":"Bioavailability of quercetin: Problems and promises","volume":"20","author":"Cai","year":"2013","journal-title":"Curr Med Chem"},{"issue":"3","key":"10.1002\/pros.23024-BIB0036|pros23024-cit-0036","doi-asserted-by":"crossref","first-page":"289","DOI":"10.17306\/J.AFS.2014.3.7","article-title":"The structure, occurrence and biological activity of ellagitannins: A general review","volume":"13","author":"Lipinska","year":"2014","journal-title":"Acta Sci Pol Technol Aliment"},{"key":"10.1002\/pros.23024-BIB0037|pros23024-cit-0037","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1749-6632.2010.05842.x","article-title":"Bioavailability of resveratrol","volume":"1215","author":"Walle","year":"2011","journal-title":"Ann NY Acad Sci"},{"issue":"1","key":"10.1002\/pros.23024-BIB0038|pros23024-cit-0038","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/pcan.2013.40","article-title":"The effect of the frequency and duration of PSA measurement on PSA doubling time calculations in men with biochemically recurrent prostate cancer","volume":"17","author":"Paller","year":"2014","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"12)","key":"10.1002\/pros.23024-BIB0039|pros23024-cit-0039","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1093\/carcin\/bgn212","article-title":"Manganese superoxide dismutase (MnSOD) gene polymorphism, interactions with carotenoid levels and prostate cancer risk","volume":"29","author":"Mikhak","year":"2008","journal-title":"Carcinogenesis"}],"container-title":["The Prostate"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fpros.23024","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fpros.23024","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/pros.23024\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,8]],"date-time":"2020-08-08T11:27:27Z","timestamp":1596886047000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/pros.23024"}},"subtitle":["Phase I Trial of MPX in BCR PCa"],"short-title":[],"issued":{"date-parts":[[2015,5,27]]},"references-count":39,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2015,10]]}},"URL":"https:\/\/doi.org\/10.1002\/pros.23024","archive":["Portico"],"relation":{},"ISSN":["0270-4137"],"issn-type":[{"value":"0270-4137","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5,27]]}}}